KNSTRN also contributes to therapy resistance potentially through ER stress pathways in bladder cancer (18, 19), and its genetic variants underscore its potential as a diagnostic and therapeutic target (20). The gene discussed is KNSTRN; the disease is urinary bladder cancer.